6 results for "Tianshi Lu"
Showing 1–6 · 0.25 seconds · RSS
-
Journal Article
Single-cycle contact-interference hybrid lithography for scalable fabrication of arrayed quadrant micro-polarizer structures
The advantages of polarization imaging can be readily leveraged in remote sensing applications by applying subwavelength metal grating arrays in standard optical imaging systems. However, the efficient fabrication of these arrays remains a significant challenge due to their dual size-scale…
-
Journal Article Full text
A Low-Autogenous-Shrinkage Alkali-Activated Slag and Fly Ash Concrete
Alkali-activated slag and fly ash (AASF) materials are emerging as promising alternatives to conventional Portland cement. Despite the superior mechanical properties of AASF materials, they are known to show large autogenous shrinkage, which hinders the wide application of these eco-friendly…
-
Journal Article Full text
Experimental Design and Implementation of Vision-Based Sorting Using SCARA Robotic Arms
Conventional industrial manipulators are often costly and come with steep learning curves, which limits their scalability in hands-on robotics education. This paper presents a compact and modular vision-guided sorting platform based on a 4-DOF SCARA robot, designed for rapid assembly…
-
Journal Article
DNA Repair Gene Mutations as Predictors of Immune Checkpoint Inhibitor Response beyond Tumor Mutation Burden
Summary: Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy, but prediction of their benefit is challenging. Neoantigens generated through impaired non-mismatch DNA repair may result in greater ICI activity. By analyzing 1,661 ICI-treated patients, we show that deletions and…
-
Journal Article
Non-small cell lung cancer molecular subtypes and vulnerability to immunotherapy treatment combinations
Abstract The phase 3 IMpower150 trial in treatment-naïve patients with metastatic non-small-cell lung cancer (NSCLC) demonstrates significantly longer progression-free (PFS) and overall survival (OS) with first-line atezolizumab (anti-PD-L1)-bevacizumab (anti-VEGF)-carboplatin-paclitaxel (ABCP)…